Correlation Between Merck and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Eli Lilly and, you can compare the effects of market volatilities on Merck and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Eli Lilly.

Diversification Opportunities for Merck and Eli Lilly

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Merck and Eli is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Merck i.e., Merck and Eli Lilly go up and down completely randomly.

Pair Corralation between Merck and Eli Lilly

Considering the 90-day investment horizon Merck Company is expected to under-perform the Eli Lilly. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 1.13 times less risky than Eli Lilly. The stock trades about -0.1 of its potential returns per unit of risk. The Eli Lilly and is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  79,277  in Eli Lilly and on December 26, 2024 and sell it today you would earn a total of  3,399  from holding Eli Lilly and or generate 4.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Eli Lilly and

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Eli Lilly 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong essential indicators, Eli Lilly is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Merck and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Eli Lilly

The main advantage of trading using opposite Merck and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind Merck Company and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Share Portfolio
Track or share privately all of your investments from the convenience of any device